(21-07-10) FDA Finally Admits That Drugs for Crohn's Disease and Arthritis May Promote Cancer

by David Gutierrez, staff writer

The FDA has ordered makers of drugs for a variety of inflammatory diseases to
add a "black box warning" about an increased risk of cancer in children and
adolescents.

A black box warning is the most severe warning that the FDA can place on a
product without withdrawing it from the market.

The FDA began analyzing the drugs, known as tumor necrosis factor (TNF)
blockers, when reports emerged that dozens of children had developed cancer
while taking the drugs. TNF blockers are used to treat inflammatory and
autoimmune diseases such as Crohn's disease and rheumatoid arthritis. They
include adalimumab (marketed as Humira), certolizumab pegol (marketed as
Cimzia), etanercept (marketed as Enbrel), golimumab (marketed as Simponi) and
infliximab (marketed as Remicade.

"FDA announced that it has completed its analysis of TNF blockers and has
concluded that there is an increased risk of lymphoma and other cancers
associated with the use of these drugs in children and adolescents,"
spokesperson Crystal Rice said . "This new safety information is now being
added to the boxed warning for these products."

The drugs already carry warnings about the risk of fungal infections and other
side effects.

Since people with the inflammatory diseases that TNF blockers treat are
already at an increased risk of cancer, those who take the drugs are at
particularly high risk.

"It's good to have this information out there," said Patience White of the
Arthritis Foundation. "It gives people with arthritis an opportunity to go to
their doctor and talk about the risk/benefits."

The FDA advises all patients currently taking TNF blockers that the drugs may
increase their risk of lymphoma, leukemia and other cancers; may worsen pre-
psoriasis; and may increase the risk of psoriasis. Such patients should watch
for cancer warning signs such as swollen lymph nodes in the neck, underarms or
groin; unexpected weight loss or fatigue; or easy bruising or bleeding. Any
such symptoms should be discussed with a doctor. Patients should not stop or
change prescription drugs without consulting a physician first.

Sources for this story include: health.usnews.com.


Source: NaturalNews

News

---

In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.